All posts by medical

The immunology of renal cell carcinoma. – UroToday

Renal cell carcinoma (RCC) is the most common type of kidney cancer and comprises several subtypes with unique characteristics. The most common subtype (~70% of cases) is clear-cell RCC. RCC is considered to be an immunogenic tumour but is known to mediate immune dysfunction in large part by eliciting the infiltration of immune-inhibitory cells, such asregulatory T cells and myeloid-derived suppressor cells, into the tumour microenvironment. Several possible mechanisms have been proposed to explain how these multiple tumour-infiltrating cell types block the development of an effective anti-tumour immune response, including inhibition of the activity of effector T cells and of antigen presenting cells via upregulation of suppressive factors such as checkpoint molecules. Targeting immune suppression using checkpoint inhibition has resulted in clinical responses in some patients with RCC and combinatorial approaches involving checkpoint blockade are now standard of care in patients with advanced RCC. However, a substantial proportion of patients do not benefit from checkpoint blockade. The identification of reliable biomarkers of response to checkpoint blockade is crucial to facilitate improvements in the clinical efficacy of these therapies. In addition, there is a need for the development of other immune-based strategies that address the shortcomings of checkpoint blockade, such as adoptive cell therapies.

Nature reviews. Nephrology. 2020 Jul 30 [Epub ahead of print]

C Marcela Daz-Montero, Brian I Rini, James H Finke

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. ., Vanderbilt University Medical Center, Nashville, TN, USA., Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. .

PubMed http://www.ncbi.nlm.nih.gov/pubmed/32733094

Read more:
The immunology of renal cell carcinoma. - UroToday

What medical residents are paidand what they really think about their bosses – The Daily Briefing

Residents in allergy and immunology, hematology, plastic surgery, rheumatology, and specialized surgery reported the highest salaries this year, while those in family medicine reported the lowest, according to Medscape's "Residents Salary & Debt Report 2020."

Advisory Board's take: Why it's so important to get physician compensation right

For the report, researchers surveyed 1,659 medical residents across more than 30 specialties from April 3 to June 1.

According to the report, the respondents reported an average annual salary of $63,400 this year, up about 3% from an average of $61,200 last year. About 70% of the respondents reported having at least $50,000 in medical school debt, with almost one quarter reporting having more than $300,000 in medical school debt. Meanwhile, 23% of respondents reported having no medical school debt.

According to the report, the residents with the highest salaries reported working in allergy and immunology, hematology, plastic surgery, rheumatology, and specialized surgery, with an average annual salary of $69,500. In comparison, the residents with the lowest salaries reported working in family medicine, with an average annual salary of $58,500.

Overall, 43% of respondents said they thought their compensation was fair, including 42% of male residents (who reported an average salary of $63,700) and 45% of female residents (who reported an average salary of $63,000)down from 47% and 49% of male and female respondents in 2019, respectfully. This was the sixth consecutive year that more female residents reported being happy with their compensation when compared with male residents, according to the report.

Among the 57% of residents who said they were dissatisfied with their compensation, 81% said the compensation doesn't adequately reflect the number of hours they work, and 77% said the compensation isn't comparable to pay received by other medical staff, such as PAs and nurses.

Respondents also weighed in on their relationships with attending physicians.

Eighty-one percent of the respondents said they were very/somewhat satisfied with attending physicians' treatment of residents and 88% said their relationships with attending physicians were very good or good. Most respondents expressed positive views on their relationships with nurses and PAs, as well.

However, one resident said Covid-19 has caused a lot of attending physicians to stay home "while residents [worked] beyond and above responsibilities." As such, there was "no mentorship and almost no education," the respondent added.

But overall, 89% of respondents said they thought their degree of supervision by attending physicians was appropriate, while 7% said they thought they received too little supervision and 4% thought they received too much.

About 77% of respondents said the most rewarding part of being a resident is the opportunity to gain clinical knowledge and experience. Many respondents also cited performing well in their jobs and the gratitude of and relationships with patients as rewarding parts of their jobs.

When asked about the biggest challenge faced in residency, 27% of respondents in years one to four of residency and 32% in years five to eight named work-life balance. Respondents also cited a fear of failure and debt, among other things, as challenges faced during residency.

In addition, Covid-19 posed new challenges for some residents this year, according to the report. About 30% of the respondents said their training left them unprepared to handle Covid-19, while 40% said their training had prepared them and 31% said they were unsure. One respondent even said she thinks the entire U.S. health care system was unprepared to handle Covid-19, according to the report (Martin, "Residents Salary & Debt Report 2020," Medscape, 8/7).

See the original post here:
What medical residents are paidand what they really think about their bosses - The Daily Briefing

UGA ranked among top universities fighting COVID-19 – University of Georgia

The university was recognized for research on the development of new vaccines designed to protect against the virus that causes COVID-19

The University of Georgia has been ranked among a list of top 10 schools working to solve the coronavirus pandemic by Successful Student. UGA was recognized specifically for research on the development of new vaccines designed to protect against SARS-CoV-2, the virus that causes COVID-19.

Other universities in the top 10 include Harvard University, the University of Oxford and Johns Hopkins University. Successful Student published their rankings online.

We have an opportunity now to use our technology to help people. And, at the University of Georgia, we have the people, and we have the facilities. We have been able to quickly mobilize resources to develop this vaccine. Biao He

Scientists in laboratories across the university began work on new vaccines and therapeutics from the moment COVID-19 emerged as a global threat.

Biao He, the Fred C. Davison Distinguished University Chair in Veterinary Medicine at UGA, has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models.

His vaccine is based on a viral delivery platform containing modified strains of a virus that cause kennel cough in dogs called parainfluenza virus 5, or PIV5. The modified viruses produce proteins found in coronaviruses, specifically the spike proteins that form the crown or corona for which they are named. After the vaccine has been administered, cells are infected with the PIV5 virus. The body then begins to mount a defense to the spike proteins produced by the modified virusultimately promoting an immunity to infection.

We have an opportunity now to use our technology to help people, he said. And, at the University of Georgia, we have the people, and we have the facilities. We have been able to quickly mobilize resources to develop this vaccine.

He hopes that the SARS-CoV-2 vaccine will be ready for FDA approval by the end of the year.

Ted Ross, Georgia Research Alliance Eminent Scholar and director of UGAs Center for Vaccines and Immunology. (Photo by Peter Frey/UGA)

Scientists in the lab of Ted M. Ross, Georgia Research Alliance Eminent Scholar and director of UGAs Center for Vaccines and Immunology, are also developing and testing new vaccines and immunotherapies to fight the coronavirus. Ross is working with other researchers in the center to analyze the viral genome and find targets that will prompt the immune system to create protective antibodies.

Ross has spent most of his career studying viruses and developing new vaccines and treatments to combat them, but he is perhaps best known for his efforts to develop a universal influenza vaccine that could protect against all forms of the virus and eliminate the need for seasonal flu shots.

While the lessons learned from his work on influenza and other viruses will inform his work, the coronavirus presents a unique set of challenges.

Most people already have some immunity to influenza, but nobody has immunity to this coronavirus, which is one reason it has spread so quickly, Ross said. The scientific community is hard at work, but theres still so much we dont know about this virus, and it will take time to gather quality data.

The virus that causes COVID-19 is studded on its exterior with spike proteins, a key component in its ability to infect human cells. Rob Woods and Parastoo Azadi, both researchers in UGAs Complex Carbohydrate Research Center, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.

Rob Woods and Parastoo Azadi are investigating the proteins and sugars on the surface of the COVID-19 virus with the goal of finding information that could lead to vaccines and therapeutics. (Submitted photo.)

SARS-CoV-2 spike proteins latch onto cells and force the virus through the cell membrane. The human immune system detects foreign proteins, like the spike protein, by recognizing amino acid sequences that are present, Woods said.

But if a pathogen puts a sugar on the proteins surface, it can mask the amino acids, he said. One sugar can mask a whole cluster of amino acids so our antibodies cant see them. Many viruses do thisinfluenza and hepatitis C, for example.

The protein is a smooth surface shielded by sugars that move like trees in the wind. That makes it harder for the human immune system to find the targetthe proteins surface.

I always use the analogy of glycans as trees in the wind. Some of them are floppy, and some of them are more stiff, Woods said. Were looking for ones that we can get under or around.

The rest is here:
UGA ranked among top universities fighting COVID-19 - University of Georgia

Cell Separation Technologies Market Research Report by Technology, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of…

New York, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Separation Technologies Market Research Report by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913778/?utm_source=GNW

The Global Cell Separation Technologies Market is expected to grow from USD 5,347.52 Million in 2019 to USD 12,724.42 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.54%.

Market Segmentation & Coverage:This research report categorizes the Cell Separation Technologies to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the Cell Separation Technologies Market studied across Fluorescence-activated Cell Sorting, Immunomagnetic Cell Separation, and Microfluidic Cell Separation.

Based on Application, the Cell Separation Technologies Market studied across Cancer Research, Immunology, and Stem Cell Research.

Based on End User, the Cell Separation Technologies Market studied across Biotechnology and Pharmaceutical Companies and Hospitals and Diagnostic Laboratories.

Based on Geography, the Cell Separation Technologies Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Separation Technologies Market including BD Biosciences, Life Technologies Corporation, Merck Millipore, Miltenyi Biotec GmbH, STEMCELL Technologies, Inc., and Terumo BCT, Inc..

FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Separation Technologies Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Cell Separation Technologies Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Separation Technologies Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Separation Technologies Market?4. What is the competitive strategic window for opportunities in the Global Cell Separation Technologies Market?5. What are the technology trends and regulatory frameworks in the Global Cell Separation Technologies Market?6. What are the modes and strategic moves considered suitable for entering the Global Cell Separation Technologies Market?Read the full report: https://www.reportlinker.com/p05913778/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Here is the original post:
Cell Separation Technologies Market Research Report by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of...

Editorial Article: From cannabis to COVID: Discover the power of RNA in situ hybridization – SelectScience

Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health

In this expert interview, we hear from Dr. Jeremy Hirota about his work in the Hirota Lab at McMaster University and how he is working to develop an internationally recognized translational research program for respiratory health, focusing on lung health and disease.

The Hirota lab uses a research strategy involving in vitro cell culture models, in vivo pre-clinical models, and clinical studies. The research of the lab is guided by three mutually reinforcing foci, Hirota explains, patient-oriented research on respiratory mucosal immunology in health and disease; small molecule drug discovery programs for commercialization opportunities; and pure basic science characterization of the biology behind innate immune receptor and related signaling pathways.

The Hirota Lab has published an impressive volume of peer-reviewed research relating to precision medicine, cell transporters, cannabis, tissue engineering, and most recently COVID-19. An invaluable tool throughout its work has been the RNAscope technology from Advanced Cell Diagnostics, which has been used for research into a variety of biomarkers. This RNA in situ hybridization multiplexing technology has enabled the profiling and identification of various cell transporters and receptors in human lung tissue. A single cell can be identified via a specific marker in one channel, whilst concurrently looking for the co-expression of other target molecules in the other available channels. This molecular approach complements traditional pathology that uses serial sections of H&E (hematoxylin and eosin) histological stains for tissue morphology assessment and cell identification, followed by staining for molecules of interest.

We have used RNAscope to confirm the in situ presence of gene transcripts for our molecules of interest, Hirota explains. However, we are only just beginning to realize the potential of this technology and hope to leverage this further in the future.

The Hirota lab has used this approach to provide evidence for the expression of cannabinoid receptors 1 and 2 in human airway epithelial cells at the gene level, and, due to the teams experience working with airway epithelial cells and lung immunology, it has applied these learnings to help tackle SARS-CoV-2. With access to COVID-19 autopsy lung tissue samples, the lab is now assessing candidate SARS-CoV-2 receptors to identify respiratory mucosal immune responses that are predictive of negative SARS-CoV-2 infection outcomes. Regarding this current work, Hirota shares that: It appears that the SARS-CoV-2 virus is present in areas of lung tissue that do not express the proposed receptor, ACE-2. This suggests that alternate receptors for the virus, or other mechanisms for virus entry, exist. The lab is currently working to confirm and subsequently publish this work.

Hirota explains how due to the ongoing pandemic his team has needed to find new ways to work collaboratively, around the clock, and ensure that it is following the recommendations designed to limit the spread of SARS-CoV-2, whilst pushing forward COVID-19 research that aims to help patients, healthcare systems, and governing bodies. The current environment is constraining, says Hirota. We are following social distancing policies in the workplace and currently have limited numbers of staff in the labs.

Looking to the future, Hirota sees several opportunities for exciting advances in precision medicine treatments and diagnostics, including the merging of molecular technologies, well-phenotyped patient samples, and improved informatics technologies. We hope to be at the forefront of this work, Hirota concludes, working with academic and industry partners to leverage respective strengths and ensure that our research makes it to market to improve health and wellbeing on a global scale.

Find out more about RNA ISH capabilities with these expert interviews and resources:

See more here:
Editorial Article: From cannabis to COVID: Discover the power of RNA in situ hybridization - SelectScience

Paul Adams Elected to Executive Board of Directors of National Organization – University of Arkansas Newswire

Photo Submitted

Paul Adams

Paul Adams, associate professor in the Department of Chemistry and Biochemistryin the Fulbright College of Arts and Sciences, has been elected to the Executive Board of Directors of the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE).

He will officially take office Oct.1,and his term will be for 3 years.

Established in 1972, the mission of NOBCChE is to build an eminent cadre of successful diverse global leaders in STEM and advance their professional endeavors by adding value to their academic, development, leadership, and philanthropic endeavors throughout the life-cycle of their careers.

To that end, educational partnerships with school districts, municipalities, businesses, universities, and other organizations in the public and private sectors have been established to provide and support local, regional, national, and global programs that assist people of color in fully realizing their potential in academic, professional, and entrepreneurial pursuits in chemistry, chemical engineering, and allied fields.

NOBCChE is governed by the Executive Board of Directors who serve to guide the direction of the organization and provide for continuity in its objectives and practices.

Adams, also a faculty member in the U of A's interdisciplinary cellular and molecular biology program, earned a B.S. in biochemistry from Louisiana State University in Baton Rouge, Louisiana, and a Ph.D. in biophysical chemistry from Case Western Reserve University in Cleveland, Ohio.

Adams' research and scholarly activities have garnered federal funding from the National Institutes of Health, the National Science Foundation, as well as from state agencies such as the Arkansas Biosciences Institute, the Arkansas Science and Technology Authority, and the Winthrop P. Rockefeller Foundation at the University of Arkansas for Medical Sciences.

He has directed the research projects of over 50 Honors, undergraduate, graduate and postdoctoral students in his laboratory at the university, and has mentored many other students since arriving to the U. of A.

Honors and awards Adams has recently received include: the William and Wilma Haines Distinguished Lecturer in Biochemistry, Wabash College, Crawfordsville, IN (2017); the Distinguished Faculty Award, The Honors College (2017); Top 10 Most Outstanding Faculty Member, University of Arkansas Student Government and Student Alumni Associations (2018); Faculty Researcher National Role Model, National Minority Access Inc. (2019); Lifetime Achievement Award, Northwest Arkansas Martin Luther King Jr. Council (2020)

Since 2017, Adams has served as principal investigator of an NSF grant that funded the Path to Graduation program, which recruits talented high school students from underrepresented populations to help them thrive and succeed at the university. Thus far, approximately 40 percent of these students have become honors students and 100% have graduated.

In December 2019, Adams was selected as a member of the first cohort of theUARK Leaders Program,a program offered through the Office of the Provost, the Office of Human Resources and Walton College of Business Executive Education. This new leadership development program was launched this spring to support the professional growth of influential and up-and coming university leaders while enhancing collaboration and innovation on campus.

Read the original:
Paul Adams Elected to Executive Board of Directors of National Organization - University of Arkansas Newswire

Electrolyte and Biochemistry Analyzers Market Analysis, Size, Regional Outlook, Competitive Strategies and Forecasts to 2025 – Bulletin Line

The research report on Electrolyte and Biochemistry Analyzers market now available with Market Study Report, LLC, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Electrolyte and Biochemistry Analyzers market.

Executive Summary:

The research report on Electrolyte and Biochemistry Analyzers market delivers vital data regarding this industry landscape while elaborating on the major growth drivers, limitations & challenges, opportunities, and future prospects impacting the business outlook.

Request a sample Report of Electrolyte and Biochemistry Analyzers Market at:https://www.marketstudyreport.com/request-a-sample/2820948?

According to the study, the Electrolyte and Biochemistry Analyzers market is expected to register a CAGR of XX% during the study period.

Crucial insights pertaining to the regional scope, competitive scenario and other factors influencing the growth pattern of each market segment are encompassed in the document. In addition, the report gauges the impact of COVID-19 outbreak on the revenue graph of this market.

Market Rundown:

Regional Analysis:

Ask for Discount on Electrolyte and Biochemistry Analyzers Market Report at:https://www.marketstudyreport.com/check-for-discount/2820948?

Product terrain outline:

Application range overview:

Competitive arena review:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-electrolyte-and-biochemistry-analyzers-market-growth-2020-2025

Related Reports:

1. Global Anaesthesia Trolley Market Growth 2020-2025The Anaesthesia Trolley Market Report offer the complete scenario of the industry and valuation of upcoming Trends for future market. It also gives the analytic of enduring growth factor, trends and statistic of Anaesthesia Trolley Market industry. The Anaesthesia Trolley Market has been outlined by overall information and analysis.Read More: https://www.marketstudyreport.com/reports/global-anaesthesia-trolley-market-growth-2020-2025

2. Global Medical Rolling Carts Market Growth 2020-2025Medical Rolling Carts Market report starts from illustration of Industry Chain structure, and portrays industry condition, at that point investigations advertise size and figure of Medical Rolling Carts by item, district and application, likewise, this report presents showcase rivalry circumstance among the merchants profile, plus, advertise value examination and esteem chain highlights are canvassed in this report.Read More: https://www.marketstudyreport.com/reports/global-medical-rolling-carts-market-growth-2020-2025

Read More Reports On: https://www.marketwatch.com/press-release/vacuum-insulated-pipe-market-size-future-scope-demands-and-projected-industry-growths-to-2026-2020-08-12

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

See the original post here:
Electrolyte and Biochemistry Analyzers Market Analysis, Size, Regional Outlook, Competitive Strategies and Forecasts to 2025 - Bulletin Line

Using nature’s blueprint to expand catalysis with Earth-abundant metals – Science Magazine

Making chemistry less precious

Much of modern chemistry relies on catalysis by precious metals such as platinum, palladium, and rhodium. By contrast, more abundant metals such as iron and copper suffice in biochemistry. Bullock et al. review the opportunities presented from the study of enzymes to shift the balance in synthetic catalysts further toward the use of these abundant metals. Whether by modifying the enzymes themselves or by designing ligand and support architectures that take advantage of the cheaper metals' characteristic electron transfer properties, recent work points toward substantial progress.

Science, this issue p. eabc3183

Catalysis has had a transformative impact on society, playing a crucial role in the production of modern materials, medicines, fuels, and chemicals. Precious metals have been the cornerstone of many industrial catalytic processes for decades, providing high activity, stability, and tolerance to poisons. In stark contrast, redox catalysis essential to life is carried out by metalloenzymes that feature exclusively Earth-abundant metals (EAMs). The terrestrial abundance of some EAMs is 104 times that of precious metals, and thus their increased use would lead to reduced cost and environmental footprint. In addition to these practical considerations, EAMs display distinct reactivity profiles that originate from their characteristic electronic structure, thermochemistry, and kinetics. The behavior of EAMs provides compelling scientific opportunities for catalyst design. We assert that natures blueprint provides essential principles for vastly expanding the use of EAMs in sustainable catalysis.

Exquisite tuning of the local environment around EAM active sites is key to enabling their use in catalysis. Such control is achieved in enzymatic catalysis by directed evolution of the amino acid environment, resulting in engineered enzymes with extraordinary catalytic performance. Similarly in molecular catalysis, modifying the steric and electronic properties of ligands can lead to some EAM catalysts with performance superior to that obtained from precious metal catalysts. In addition, for heterogeneous catalysts, the local environment and electronic structure of active sites can be modified by bonding to other metals or main-group elements, facilitating reaction pathways distinct from those involving precious metals. Innovations in the design of EAM catalysts demonstrate their potential to catalyze many of the reactions that traditionally relied on precious metals, although further improvements are needed in activity, selectivity, lifetime, or energy efficiency. The characteristics of EAMs point to an overarching need for improved theories and computational methods that accurately treat their multiconfigurational electronic structure.

The remarkable ability of enzymes to catalyze a variety of reactions under mild conditions, using only EAMs, highlights compelling opportunities for the discovery of new catalysis. Although enzymes are versatile platforms for harnessing the properties of EAMs, they are insufficiently robust under the harsh pH, temperature, pressure, and solvent conditions required for some industrial catalytic processes. Thus, systematic strategies are needed for directed evolution to extend the reactivity and persistence of engineered enzymes. For molecular catalysts, the tunability of the ligands provides opportunities for systematically varying the activities of EAMs. Key challenges include enhancing metal-ligand cooperativity, controlling transport to EAM active sites, and mastering the interactions of EAM centers with both metal-based and organic-based redox-active ligands. In heterogeneous catalysis, tuning the lattice environment of EAMs offers new opportunities for catalyst discovery, but for practical applications EAM catalysts should exhibit long-term stability and high active-site density. Thus, advances are needed in the synthesis of materials with tunable phase and nanostructure, as well as insights into how EAM catalysts undergo electronic and structural changes under sustained catalytic turnover. Strategies for controlling EAM reactivity patterns, coupled with advances in synthetic methods and spectroscopic and computational techniques, are critical for the systematic use of EAMs in sustainable catalysis.

Natures blueprint provides the fundamental principles for expanding the use of abundant metals in catalysis by controlling the local environment and electronic structure of metal centers. Examples include nitrogenase-based enzymatic catalysts for N2 reduction, metalloporphyrin-based molecular catalysts for reduction of oxygen and carbon dioxide, and metal chalcogenides in heterogeneous catalysis for hydrodesulfurization and hydrogen evolution reactions.

Numerous redox transformations that are essential to life are catalyzed by metalloenzymes that feature Earth-abundant metals. In contrast, platinum-group metals have been the cornerstone of many industrial catalytic reactions for decades, providing high activity, thermal stability, and tolerance to chemical poisons. We assert that natures blueprint provides the fundamental principles for vastly expanding the use of abundant metals in catalysis. We highlight the key physical properties of abundant metals that distinguish them from precious metals, and we look to nature to understand how the inherent attributes of abundant metals can be embraced to produce highly efficient catalysts for reactions crucial to the sustainable production and transformation of fuels and chemicals.

The rest is here:
Using nature's blueprint to expand catalysis with Earth-abundant metals - Science Magazine

Movie review: Lush horror-thriller Sputnik imagines what happens when an alien makes its way to Earth – Daytona Beach News-Journal

Katie Walsh| Tribune News Service

The DNA of Alien is all over Egor Abramenkos directorial debut, the Russian Soviet-era horror/sci-fi film Sputnik. Fortunately, this offspring of Ridley Scotts classic is very much its own slick, engaging psychological horror-thriller, anchored by a strong lead performance by Oksana Akinshina.

Based on Abramenkos short film The Passenger, the film, written by Oleg Malovichko and Andrei Zolotarev, imagines what happens after most sci-fi films end. In the Alien franchise, Ripley spends most of her energy making sure aliens dont make their way to Earth. But what happens if one does? How would the Soviet superpower embroiled in a space race handle the situation if they sent two into space and came back with three?

This mystery unfolds from the perspective of Tatiana (Akinshina), a brilliant doctor interested in the field of neuropsychiatry, who has been disciplined for her extreme methods to produce results in her patients. This catches the attention of Semiradov (Fedor Bondarchuk), a mysterious military man who needs her help with a recently returned amnesiac cosmonaut, Konstantin (Pyotr Fyodorov), being held at a research facility in Kazakhstan. What Tatiana finds when she arrives at the facility is a charming cosmonaut, irritated at being held for tests, whose gory secret, buried under layers of bureaucracy, only comes out at night.

With her steely exterior and empathetic superpowers, Tatiana falls into the canon of sci-fi heroines like Ripley, of course, but also Lindsey Brigman in The Abyss, Louise Banks in Arrival, even with shades of Clarice Starling in Silence of the Lambs. Although these are all beloved cinematic heroines, and Akinshina is fantastic carrying and grounding the film as the brave Tatiana, the trope is a bit overdone at this point, and the script does not stray from this rather stereotypical characterization.

However, there is so much to admire about Sputnik, with its immersive, eye-catching production design by Marina Slavina and stylish cinematography by Maxim Zhukov (the film was shot on location at the Institute of Biochemistry of the Russian Academy of Sciences in Moscow). Its the kind of film you cant look away from, thanks to the lush look and performances, particularly by Akinshina and Fyodorov. The creature design and execution is also particularly impressive.

Everything is so perfectly placed that its jarring when Abramenko loses control over the tone, particularly in transitions where tightly wound lab scenes stumble into soaring drone shots soundtracked to an intense yet generic-sounding score, which feels like different films mashed together. The genre swerves from sci-fi to horror to psychological thriller to melodrama, but in a way, it works. Its clear Abramenko wants to serve a whole full meal of movie, and in stretching the dynamic range of emotion he does hit on moments that are at times operatic or somewhat soapy. But in doing so, brings a new layer of story that makes Sputnik feel epic.

That play with genre is what makes this film so compelling. It starts out paying homage to its classical science fiction roots, but goes its own way, layering on melodrama and social and political commentary unique to its Russian setting and history. Yet its open-ended enough to be the kind of choose-you-own metaphor that that the best kind of sci-fi always is. Give Sputnik a whirl, and it just might take over.

SPUTNIK

3 stars

Cast: Oksana Akinshina, Fedor Bondarchuk, Pyotr Fyodorov.

Directed by Egor Abramenko.

Running time: 1 hour, 53 minutes.

No MPAA rating

In Russian with English subtitles.

Available in theaters and on demand Friday

View original post here:
Movie review: Lush horror-thriller Sputnik imagines what happens when an alien makes its way to Earth - Daytona Beach News-Journal

New NSF Grant Awarded to Hendrix Biology Professor Duina – Hendrix College Events and News

CONWAY, Ark. (August13, 2020) Dr. Andrea Duina, a professor of biology and chair of the biochemistry-molecularbiology program at Hendrix College, has received a three-year, $480,000 grantfrom the National Science Foundation (NSF) that will help undergraduatestudents gain new insights into some of the fundamental mechanisms thatregulate how genes are utilized by cells. This grant is the latest in a seriesof NSF grants awarded to Duina for research that increases the scientificcommunitys understanding of life beginning at the cellular level.

Since propergene regulation is essential for most cellular and organismal functions, thesestudies address questions with far-ranging implications, Duina said. For ourstudies, we use the budding yeast Saccharomyces cerevisiae as the modelsystem, and given the high degree of functional conservation across all life forms,findings from these studies will shed new light into processes relevant to allorganisms, including humans.

This grant, oneof five received by Duina from the NSF for undergraduate research in his lab at Hendrix,will provide more opportunities for Hendrix students to carry out cutting-edgeresearch.

Students willfurther develop their skills in various aspects of the scientific process,including experimental design and execution, data interpretation andevaluation, science communication to other scientists and to the generalpublic, and critical evaluation of current research literature, Duina said.

In addition tothe grants direct benefit to students who conduct research in Duinaslaboratory, it will have an expanded impact at Hendrix through the elements ofthis project that Duina plans to incorporate into some of the courses he teaches.

This NSF grantalso stands as a testament to Hendrixs strong commitment in promotingstate-of-the art STEM undergraduate research on campus, he said. Hendrix canbe proud of its role in developing well-rounded and well-prepared scientists.

About Hendrix College

A private liberalarts college in Conway, Arkansas, Hendrix College consistently earnsrecognition as one of the countrys leading liberal arts institutions, and isfeatured in Colleges That Change Lives: 40 Schools That Will Changethe Way You Think About Colleges.Its academic quality and rigor, innovation, and value have established Hendrixas a fixture in numerous college guides, lists, and rankings. Founded in 1876,Hendrix has been affiliated with the United Methodist Church since 1884. Tolearn more, visit http://www.hendrix.edu.

Read more:
New NSF Grant Awarded to Hendrix Biology Professor Duina - Hendrix College Events and News